Cor Vasa 2012, 54(9-10):e295-e299 | DOI: 10.1016/j.crvasa.2012.09.002

Is it possible to operate four heart valves in a patient with heart failure, congenital heart disease and pulmonary hypertension?

Marie Zvěřinováa,*, Jana Popelováa,c, Petr Pavela, Roman Gebauera,c, Pavel Jehličkaa, Miroslav Rubáčeka, Milan Čechb, Štěpán Černýa
a Kardiocentrum, Nemocnice Na Homolce, Praha, Česká republika
b Interní oddělení, Nemocnice Na Homolce, Praha, Česká republika
c Dětské kardiocentrum, Fakultní nemocnice Motol, Praha, Česká republika

We describe a 60-year-old man with the history of radical correction of the tetralogy of Fallot (TOF) in the year 1964. This patient has had a long lasting decompensation of a severe right heart failure with ascites and pulmonary hypertension. On echocardiography he had residual mild pulmonary stenosis (PS) and severe pulmonary and tricuspid regurgitation (TR), moderate aortic and mitral regurgitation. He also had residual ventricular septal defect (VSD) and severe pulmonary hypertension with the maximal gradient on TR 83 mmHg. He was considered unoperable by his cardiologist, however, the patient decided to undergo a high-risk operation. The operation comprised pulmonary and aortic valve replacement with bioprosthesis, mitral and tricuspid repair, closure of ventricular septal defect, bilateral MAZE and volumereduction of both atria. After a very complicated postoperative course with multiorgan failure he recovered and was discharged home 2 months after operation. The NYHA class improved from IV before operation to II. Twenty months after this operation he experienced infective endocarditis with a leak on the aortic bioprosthesis. He was reoperated with reimplantation of a new aortic bioprosthesis and with a very complicated postoperative course. Sildenafil was added to his therapy due to the persistent severe pulmonary hypertension. He survived and was discharged home. The presented unique high-risk complex reoperation of a congenital heart disease with pulmonary hypertension can be performed only by a very experienced cardiosurgical and cardio-anesthesiological team with a high level of the early and late postoperative care.

Keywords: Heart failure; Operation of adult with congenital heart disease; Pulmonary hypertension; Sildenafil; Tetralogy of Fallot

Received: May 28, 2012; Revised: August 28, 2012; Accepted: September 1, 2012; Published: September 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zvěřinová M, Popelová J, Pavel P, Gebauer R, Jehlička P, Rubáček M, et al.. Is it possible to operate four heart valves in a patient with heart failure, congenital heart disease and pulmonary hypertension? Cor Vasa. 2012;54(9-10):e295-299. doi: 10.1016/j.crvasa.2012.09.002.
Download citation

References

  1. C.A. Warnes, R. Liberthson, G.K. Danienson, et al., Task force 1: the changing profile of congenital heart disease in adult life, Journal of the American College of Cardiology 37 (5) (2001) 1170-1175. Go to original source... Go to PubMed...
  2. J. Popelová, E. Oechslin, H. Kaemmerer, et al., Congenital Heart Disease in Adults, Informa Healthcare, London, 2008, pp. 40-50. Go to original source...
  3. J. Popelová, Congenital Heart Disease in Adults (in Czech: Vrozené srdeční vady v dospělosti), Grada Publishing, Praha, 2003, pp. 101-118.
  4. J. Popelová, Š. Černý, R. Gebauer, et al., Six-year experience with cardiac surgery in adults with congenital heart disease (In Czech: Šestileté zkušenosti s operacemi vrozených srdečních vad u dospělých), Časopis lékařů českých 150 (4) (2011) 293-296.
  5. J. Popelová, M. Voříšková, B. Hučín, et al., How are patients faring 30 years after radical tetralogy of Fallot repair? (In Czech: Jak se daří pacientům 30 let po radikální korekci Fallotovy tetralogie), Cor et Vasa 52 (3) (2010) 154-161.
  6. E.J. Hickey, G. Veldtman, T.J. Bradley, et al., Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades, European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery 35 (2009) 156-166. Go to original source... Go to PubMed...
  7. C.W. Lillehei, H. Warden, R. DeWall, et al., The first open heart corrections of tetralogy of Fallot. A 26-31 year follow-up of 106 patients, Annals of Surgery 204 (4) (1986) 490-501. Go to original source... Go to PubMed...
  8. H. Baumgartner, P. Bonhoffer, N.M. De Groot, et al., ESC Guidelines for the management of grown-up congenital heart disease (new version 2010), European Heart Journal 31 (2010) 2937-2939.
  9. T. Ishizaka, H. Ichikawa, Y. Sawa, et al., Prevalence and optimal management strategy for aortic regurgitation in tetralogy of Fallot, European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery 26 (2004) 1080-1086. Go to original source... Go to PubMed...
  10. J. Popelová, F. Kölbel, P. Dostálová, M. Voříšková, Echocardiography in adults with congenital heart disease, Experimental nad Clinical Cardiology 4 (2) (1999) 89-93.
  11. M.A. Gatzoulis, S. Balaji, S.A. Webber, et al., Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study, Lancet 356 (2000) 975-981. Go to original source... Go to PubMed...
  12. T. Oosterhof, A. van Straten, H.W. Vliegen, et al., Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance, Circulation 116 (2007) 545-551. Go to original source... Go to PubMed...
  13. P. Jansa, J. Popelová, H. Al-Hiti, et al., Chronic pulmonary hypertension. Guidelines of the Czech Society of cardiology. (In Czech: Chronická plicní hypertenze. Doporučený diagnostický a léčebný postup České kardiologické společnosti) 2010, Cor et Vasa 53 (3) (2011) 169-182.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.